{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:29:04Z","timestamp":1773235744899,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","nwhjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nursing for Women's Health"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1111\/j.1751-486x.2012.01776.x","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T13:11:27Z","timestamp":1355836287000},"page":"482-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["An Overview of Chronic Vaginal Atrophy and Options for Symptom Management"],"prefix":"10.1016","volume":"16","author":[{"given":"Nancy Fugate","family":"Woods","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1111\/j.1751-486X.2012.01776.x_bb0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1471-0528.1996.tb09741.x","article-title":"A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy","volume":"103","author":"Ayton","year":"1996","journal-title":"British Journal of Obstetrics & Gynaecology"},{"key":"10.1111\/j.1751-486X.2012.01776.x_bb0015","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/0378-5122(95)00956-6","article-title":"Urogenital ageing: an old problem newly recognized","volume":"22","author":"Bachmann","year":"1995","journal-title":"Maturitas"},{"issue":"4","key":"10.1111\/j.1751-486X.2012.01776.x_bb0020","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/gme.0b013e3181a48c4e","article-title":"Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally","volume":"16","author":"Bachmann","year":"2009","journal-title":"Menopause"},{"issue":"3","key":"10.1111\/j.1751-486X.2012.01776.x_bb0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s001920050040","article-title":"Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and a placebo-controlled multicenter study. Vaginal Ring Study Group","volume":"10","author":"Casper","year":"1999","journal-title":"International Urogynecology Journal and Pelvic Floor Dysfunction"},{"key":"10.1111\/j.1751-486X.2012.01776.x_bb0030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0378-5122(03)00080-X","article-title":"The effect of a soy rich diet on the vaginal epithelium in postmenopause: a randomized double blind trial","volume":"45","author":"Chiechi","year":"2003","journal-title":"Maturitas"},{"key":"10.1111\/j.1751-486X.2012.01776.x_bb0035","first-page":"29","article-title":"Progress in vulvovaginal atrophy treatments","volume":"35","author":"Chollet","year":"2010","journal-title":"Female Patient"},{"issue":"3","key":"10.1111\/j.1751-486X.2012.01776.x_bb0040","first-page":"351","article-title":"A prospective population-based study of menopausal symptoms. [Research Support, Non-U.S. Gov't]","volume":"96","author":"Dennerstein","year":"2000","journal-title":"Obstetrics & Gynecology"},{"issue":"6","key":"10.1111\/j.1751-486X.2012.01776.x_bb0045","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/humupd\/dmm022","article-title":"New findings from non-linear longitudinal modelling of menopausal hormone changes","volume":"13","author":"Dennerstein","year":"2007","journal-title":"Human Reproduction Update"},{"issue":"6","key":"10.1111\/j.1751-486X.2012.01776.x_bb0050","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.fertnstert.2010.03.076","article-title":"Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis","volume":"94","author":"Dorr","year":"2010","journal-title":"Fertility & Sterility"},{"issue":"3","key":"10.1111\/j.1751-486X.2012.01776.x_bb0055","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/13697137.2010.483297","article-title":"Minimized estradiol absorption with ultra-low-dose 10 \u03bcg 17\u03b2-estradiol vaginal tablets","volume":"13","author":"Eugster-Hausmann","year":"2010","journal-title":"Climacteric"},{"key":"10.1111\/j.1751-486X.2012.01776.x_bb0060","first-page":"32","article-title":"Tissue changes associated with vaginal atrophy","author":"Freeman","year":"2010","journal-title":"The Clinical Advisor"},{"issue":"3","key":"10.1111\/j.1751-486X.2012.01776.x_bb0065","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/jwh.2009.1384","article-title":"Recognizing and treating urogenital atrophy in postmenopausal women","volume":"19","author":"Goldstein","year":"2010","journal-title":"Journal of Women's Health"},{"issue":"11","key":"10.1111\/j.1751-486X.2012.01776.x_bb0070","doi-asserted-by":"crossref","first-page":"e26602","DOI":"10.1371\/journal.pone.0026602","article-title":"Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe dryness","volume":"6","author":"Hummelen","year":"2011","journal-title":"PLoS One"},{"issue":"Suppl. 4","key":"10.1111\/j.1751-486X.2012.01776.x_bb0075","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3949\/ccjm.75.Suppl_4.S17","article-title":"Update on nonhormonal approaches to menopausal management","volume":"75","author":"Jenkins","year":"2008","journal-title":"Cleveland Clinic Journal of Medicine"},{"issue":"11","key":"10.1111\/j.1751-486X.2012.01776.x_bb0080","first-page":"S8","article-title":"Therapeutic options for the treatment of vaginal atrophy","volume":"22","author":"Kagan","year":"2010","journal-title":"OBG Management"},{"issue":"11","key":"10.1111\/j.1751-486X.2012.01776.x_bb0085","first-page":"S14","article-title":"Impact of vaginal atrophy on quality of life and sexuality","volume":"22","author":"Krychman","year":"2010","journal-title":"OBG Management"},{"issue":"6","key":"10.1111\/j.1751-486X.2012.01776.x_bb0090","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00404-010-1545-7","article-title":"The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause. [Randomized Controlled Trial]","volume":"283","author":"Le Donne","year":"2011","journal-title":"Archives of Gynecology & Obstetrics"},{"issue":"1","key":"10.1111\/j.1751-486X.2012.01776.x_bb0095","article-title":"Clinical approach to recognizing and managing a patient with vaginal atrophy: a guide for physician assistants","volume":"8","author":"Lehman","year":"2010","journal-title":"The Internet Journal of Academic Physician Assistants"},{"issue":"4Pt 1","key":"10.1111\/j.1751-486X.2012.01776.x_bb0100","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/gme.0b013e31815a5168","article-title":"Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women","volume":"15","author":"Levine","year":"2008","journal-title":"Menopause"},{"issue":"10","key":"10.1111\/j.1751-486X.2012.01776.x_bb0105","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1089\/jwh.2008.1281","article-title":"Vaginal estrogen therapy for the treatment of atrophic vaginitis","volume":"18","author":"Lynch","year":"2009","journal-title":"Journal of Women's Health"},{"issue":"1","key":"10.1111\/j.1751-486X.2012.01776.x_bb0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4065\/mcp.2009.0413","article-title":"Vulvovaginal atrophy","volume":"85","author":"Mac Bride","year":"2010","journal-title":"Mayo Clinic Proceedings"},{"issue":"2","key":"10.1111\/j.1751-486X.2012.01776.x_bb0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.maturitas.2005.09.011","article-title":"The effect of a soy-rich diet on urogenital atrophy: a randomized, cross-over trial","volume":"54","author":"Manonai","year":"2006","journal-title":"Maturitas"},{"issue":"24","key":"10.1111\/j.1751-486X.2012.01776.x_bb0120","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1001\/jama.1979.03300240039024","article-title":"Systemic absorption and sustained effects of vaginal estrogen creams","volume":"242","author":"Martin","year":"1979","journal-title":"JAMA"},{"issue":"11","key":"10.1111\/j.1751-486X.2012.01776.x_bb0125","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0011-393X(00)90004-3","article-title":"Effect on vaginal pH of a polycarbophil vaginal gel compared with an acidic douche in women with suspected bacterial vaginosis: a randomized, controlled study","volume":"61","author":"Milani","year":"2000","journal-title":"Current Therapeutic Research"},{"issue":"1","key":"10.1111\/j.1751-486X.2012.01776.x_bb0130","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0015-0282(16)56474-7","article-title":"Comparative study: Replens versus local estrogen in menopausal women","volume":"61","author":"Nachtigall","year":"1994","journal-title":"Fertility & Sterility"},{"issue":"3Pt 1","key":"10.1111\/j.1751-486X.2012.01776.x_bb0135","first-page":"355","article-title":"The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society","volume":"14","author":"NAMS","year":"2007","journal-title":"Menopause"},{"issue":"3","key":"10.1111\/j.1751-486X.2012.01776.x_bb0140","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/gme.0b013e31824b970a","article-title":"The 2012 hormone therapy position statement of The North American Menopause Society. [Research Support, Non-U.S. Gov't]","volume":"19","author":"NAMS","year":"2012","journal-title":"Menopause"},{"issue":"3","key":"10.1111\/j.1751-486X.2012.01776.x_bb0145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.maturitas.2010.08.001","article-title":"Women's voices in the menopause: results from an international survey on vaginal atrophy","volume":"67","author":"Nappi","year":"2010","journal-title":"Maturitas"},{"key":"10.1111\/j.1751-486X.2012.01776.x_bb0150","series-title":"Vagifem (estradiol vaginal tablets) [prescribing information]","author":"Novo Nordisk, Inc","year":"2009"},{"issue":"6","key":"10.1111\/j.1751-486X.2012.01776.x_bb0155","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.nurpra.2010.08.016","article-title":"Atrophic Vaginitis","volume":"7","author":"Pearson","year":"2011","journal-title":"The Journal for Nurse Practitioners"},{"key":"10.1111\/j.1751-486X.2012.01776.x_bb0160","series-title":"Estring (estradiol vaginal ring) [prescribing information]","author":"Pharmacia & Upjohn Company","year":"2008"},{"issue":"11","key":"10.1111\/j.1751-486X.2012.01776.x_bb0165","first-page":"S2","article-title":"Vaginal impact of menopause-related estrogen deficiency","volume":"22","author":"Pinkerton","year":"2010","journal-title":"OBG Management"},{"issue":"8","key":"10.1111\/j.1751-486X.2012.01776.x_bb0170","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1743-6109.2009.01335.x","article-title":"Prevalence and impact of vaginal symptoms among postmenopausal women","volume":"6","author":"Santoro","year":"2009","journal-title":"Journal of Sexual Medicine"},{"issue":"5","key":"10.1111\/j.1751-486X.2012.01776.x_bb0175","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/AOG.0b013e31818aa7c3","article-title":"Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet. [Clinical Trial report]","volume":"112","author":"Simon","year":"2008","journal-title":"Obstetrics & Gynecology"},{"issue":"4","key":"10.1111\/j.1751-486X.2012.01776.x_bb0180","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/AOG.0b013e3181f386bb","article-title":"Endometrial safety of ultra-low-dose estradiol vaginal tablets","volume":"116","author":"Simon","year":"2010","journal-title":"Obstetrics and Gynecology"},{"issue":"6","key":"10.1111\/j.1751-486X.2012.01776.x_bb0185","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/13697137.2010.522875","article-title":"Recommendations for the management of postmenopausal vaginal atrophy","volume":"13","author":"Sturdee","year":"2010","journal-title":"Climacteric"},{"issue":"4","key":"10.1111\/j.1751-486X.2012.01776.x_bb0190","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","author":"Suckling","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1111\/j.1751-486X.2012.01776.x_bb0195","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/13697137.2010.481058","article-title":"Endometrial safety of ultra-low-dose Vagifem 10 \u03bcg in postmenopausal women with vaginal atrophy","volume":"13","author":"Ulrich","year":"2010","journal-title":"Climacteric"},{"issue":"6","key":"10.1111\/j.1751-486X.2012.01776.x_bb0200","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/jcp.55.6.446","article-title":"The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry","volume":"55","author":"van der Laak","year":"2002","journal-title":"Journal of Clinical Pathology"},{"key":"10.1111\/j.1751-486X.2012.01776.x_bb0205","series-title":"Femring (estradiol acetate vaginal ring) [prescribing information]","author":"Warner Chilcott","year":"2010"},{"key":"10.1111\/j.1751-486X.2012.01776.x_bb0210","series-title":"Estrace (estradiol vaginal cream, USP, 0.01%) [prescribing information]","author":"Warner Chilcott","year":"2011"},{"issue":"1","key":"10.1111\/j.1751-486X.2012.01776.x_bb0215","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/13697130500087016","article-title":"Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet","volume":"8","author":"Weisberg","year":"2005","journal-title":"Climacteric"},{"issue":"12B","key":"10.1111\/j.1751-486X.2012.01776.x_bb0220","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1016\/j.amjmed.2005.09.031","article-title":"Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives","volume":"118","author":"Woods","year":"2005","journal-title":"American Journal of Medicine"},{"key":"10.1111\/j.1751-486X.2012.01776.x_bb0225","series-title":"Premarin (conjugated estrogens) vaginal cream [prescribing information]","author":"Wyeth Pharmaceuticals, Inc","year":"2010"},{"issue":"11\/12","key":"10.1111\/j.1751-486X.2012.01776.x_bb0230","first-page":"36","article-title":"Etiology, consequences, and management of vaginal atrophy","volume":"12","author":"Wysocki","year":"2008","journal-title":"American Journal of Nurse Practitioners"}],"container-title":["Nursing for Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485115307133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485115307133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T21:40:26Z","timestamp":1761687626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751485115307133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1751485115307133"],"URL":"https:\/\/doi.org\/10.1111\/j.1751-486x.2012.01776.x","relation":{},"ISSN":["1751-4851"],"issn-type":[{"value":"1751-4851","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Overview of Chronic Vaginal Atrophy and Options for Symptom Management","name":"articletitle","label":"Article Title"},{"value":"Nursing for Women's Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1751-486X.2012.01776.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 AWHONN. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}